Table 3 Cost analyses of vaccination programs in the general population
From: Health economics of rubella: a systematic review to assess the value of rubella vaccination
First author [Reference] | Gudnadottir [[22]] | Fontanesi [[21]] | Haas [[23]] |
|---|---|---|---|
Country | Iceland | USA | USA |
Year | 1985 | 2004 | 2005 |
WB income group | High | High | High |
Group targeted | Children | Children | Pregnant women |
Comparators | 1. Vaccinate all children and re-vaccinate women | 1. MMR vaccination | 1. Rubella test and rubella vaccine |
| Â | 2. Vaccinate girls and sero-negative women | 2. DTaP vaccination | 2. Rubella test and MMR vaccine |
| Â | 3. Vaccinate all children and re-vaccinate girls | 3. IPV vaccination | 3. MMR test and MMR vaccine |
| Â | 4. Vaccinate screened women | Â | 4. MMR test and rubella/MMR vaccine |
Perspective | Payer* | Payer* | Payer* |
Cost components measured | Vaccine; serology | Vaccine; personnel; syringes | Vaccine; serology |
Method of cost estimation | Micro-costing | Micro-costing | Micro-costing |
Time period for costing | One-time vaccination at different ages | One-time vaccination (complete number of doses) | One-time vaccination |
Discounting (Rate) | NA | NA | NA |
Results (2012 US$) | 1. $1,063 | 1. $30 | 1. $8 |
| Â | 2. $638 | 2. $23 | 2. $10 |
| Â | 3. $2,409 | 3. $18 | 3. $37 |
| Â | 4. $283 | Â | 4. $35 |
Stated conclusion | Vaccination of girls and of women after screening was preferable | The MMR vaccine had the highest cost per immunized child | The combined MMR test and vaccination was the most costly |
Sponsor | Iceland MOHSS | US CDC | NMBS |